Editorial: Crosstalk between epigenetics on the development of cancer and cardiovascular disease
- PMID: 36340040
- PMCID: PMC9632337
- DOI: 10.3389/fcell.2022.1027798
Editorial: Crosstalk between epigenetics on the development of cancer and cardiovascular disease
Keywords: cancer; cardiovascular disease; epigenetic drug; epigenetic modification; epigenetics.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Crosstalk between epigenetics on the development of cancer and cardiovascular disease
References
-
- Gao X. Q., Zhang Y. H., Liu F., Ponnusamy M., Zhao X. M., Zhou L. Y., et al. (2020). The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N6-methyladenosine methylation of Parp10 mRNAChromatin challenges during DNA replication and repair. Nat. Cell BiolCell 22128, 1319721–1331733. 10.1038/s41556-020-0576-y10.1016/j.cell.2007.01.030 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources